dr. jeffrey guy, who runs gw pharmaceuticals, says it has to be this way, because they're trying to do something no other pharmaceutical company in the world is attempting -- turning the actual marijuana plant into a prescription drug. >> when you look out at all of this, what comes to your mind? >> i look at this, and i think we can make generations of medicines over the next 25, 30 years. >> medicines for illnesses like alzheimer's, diabetes and epilepsy, autoimmune diseases like multiple sclerosis and crone's. the key to making these medications is inside these simple looking leaves, and understanding the hundreds of chemicals. some more therapeutic than others. those are the cannabinoids. >> in our clinical research, we're able to say what each individual cannabinoid does. each one represents a potential new medicine for us. we can then breed into the plant the materials that will provide us with a range of beneficial effects. >> designer cannabis plants are then reduced to a whole plant extract, and that's crucial according to the grand daddy of all marijuana research, israel's dr. raphael

dr. jeffrey guy, who runs gw pharmaceuticals, says it has to be this way, because they're trying to do somethingr pharmaceutical company in the world is attempting -- turning the actual marijuana plant into a prescription drug. >> when you look out at all of this, what comes to your mind? >> i look at this, and i think we can make generations of medicines over the next 25, 30 years. >> medicines for illnesses like alzheimer's, diabetes and epilepsy, autoimmune diseases like multiple sclerosis and crone's. the key to making these medications is inside these simple looking leaves, and understanding the hundreds of chemicals. some more therapeutic than others. those are the cannabinoids. >> in our clinical research, we're able to say what each individual cannabinoid does. each one represents a potential new medicine for us. we can then breed into the plant the materials that will provide us with a range of beneficial effects. >> designer cannabis plants are then reduced to a whole plant extract, and that's crucial according to the grand daddy of all marijuana research, israel's dr. raphael mashula.

dr. jeffrey guy, who runs gw pharmaceuticals, says it has to be this way, because they're trying to do somethingy in the world is attempting -- turning the actual marijuana plant into a prescription drug. >> when you look out at all of this, what comes to your mind? >> i look at this, and i think we can make generations of medicines over the next 25, 30 years. >> medicines for illnesses like alzheimer's, diabetes and epilepsy, autoimmune diseases like multiple sclerosis and crone's. the key to making these medications is inside these simple looking leaves, and understanding the hundreds of chemicals. some more therapeutic than others. those are the cannabinoids. >> in our clinical research, we're able to say what each individual cannabinoid does. each one represents a potential new medicine for us. we can then breed into the plant the materials that will provide us with a range of beneficial effects. >> designer cannabis plants are then reduced to a whole plant extract, and that's crucial according to the grand daddy of all marijuana research, israel's dr. raphael mashula. >> when they've tried

dr. jeffrey guy, who runs gw pharmaceuticals, says it has to be this way, because they're trying to do somethingher pharmaceutical company in the world is attempting -- turning the actual marijuana plant into a prescription drug. >> when you look out at all of this, what comes to your mind? >> i look at this, and i think we can make generations of medicines over the next 25, 30 years. >> medicines for illnesses like alzheimer's, diabetes and epilepsy, autoimmune diseases like multiple sclerosis and crone's. the key to making these medications is inside these simple looking leaves, and understanding the hundreds of chemicals. some more therapeutic than others. those are the cannabinoids. >> in our clinical research, we're able to say what each individual cannabinoid does. each one represents a potential new medicine for us. we can then breed into the plant the materials that will provide us with a range of beneficial effects. >> designer cannabis plants are then reduced to a whole plant extract, and that's crucial according to the grand daddy of all marijuana research, israel's dr. raphael mashul